1367 A highly-selective HPK1 inhibitor enhances T cell receptor signaling and T cell activation potential, increasing antigen recognition and efficacy of PD-1 therapy

Authors :: Andrew Nager
David Schaer
Rebecca Gallego
Eleanore Hendrickson
Sergei Timofeevski
Manqing Li
Allison Rohner
Ruth Seelige
Samuel Stoner
Christopher Dillon
Paulina Cuenca
Cinthia Jones
Sarah Firdaus
Robert Amezquita
Clifford Restaino
Derek Bartlett
Timothy Fisher
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools